Analyst Price Targets — FREQ
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 8, 2022 9:24 am | — | Chardan Capital | $1.40 | $0.41 | Benzinga | Chardan Capital Initiates Coverage On Frequency Therapeutics with Buy Rating, Announces Price Target of $7 |
Latest News for FREQ
Fremedica Launches Nikki Lyme Wellness Program Through Ergopathics Network
VANCOUVER, British Columbia, July 30, 2026 - TheNewswire – Frequency Exchange Corp. (TSXV: FREQ) (OTC: FRECF) ("Frequency”) announces that its wholly owned operating subsidiary, FREmedica Technologies Inc. (“FREmedica” or the “Company”) , announces the commercial launch of its NIKKI Lyme Wellness Program through Ergopathics. Under the commercial referral relationship, Ergopathics will make the NIKKI Lyme Wellness…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for FREQ.
U.S. House Trading
No House trades found for FREQ.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.